Hypertension, pulse, and other cardiovascular risk factors and vitamin d status in finnish men

American Journal of Hypertension

Volumn 26, Issue 8, 2013, Pages 951-956

  Ke, Liang ^a   Graubard, Barry I ^b   Albanes, Demetrius ^b   Fraser, David R ^a   Weinstein, Stephanie J ^b   Virtamo, Jarmo ^c   Brock, Kaye E ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

25(OH)D; Blood pressure; Coronary heart disease; Diabetes; Hypertension, pulse heart rate; Vitamin D status

Indexed keywords

25 HYDROXYVITAMIN D;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR RISK; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; FINLAND; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PULSE RATE; SMOKING; SYSTOLIC BLOOD PRESSURE; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

25(OH)D.; BLOOD PRESSURE; CORONARY HEART DISEASE; DIABETES; HYPERTENSION; PULSE/HEART RATE; VITAMIN D STATUS;

AGED; CARDIOVASCULAR DISEASES; COHORT STUDIES; CORONARY DISEASE; DIABETES MELLITUS; FINLAND; HEART RATE; HUMANS; HYPERTENSION; LINEAR MODELS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; RISK FACTORS; SMOKING; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84881656319     PISSN: 08957061     EISSN: 19417225     Source Type: Journal    
DOI: 10.1093/ajh/hpt051     Document Type: Article

References (20)

1. Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PF, Clinton SK, Durazo-Arvizu RA, Gallagher JC, Gallo RL, Jones G, Kovacs CS, Mayne ST, Rosen CJ, Shapses SA. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 2011; 96:53-58.
2. Rosen CJ, Adams JS, Bikle DD, Black DM, Demay MB, Manson JE, Murad MH, Kovacs CS. The nonskeletal effects of vitamin D: an Endocrine Society scientific statement. Endocr Rev 2012; 33:456-492.
3. Pittas AG, Chung M, Trikalinos T, Mitri J, Brendel M, Patel K, Lichtenstein AH, Lau J, Balk EM. Systematic review: vitamin D and cardiometabolic outcomes. Ann Intern Med 2010; 152:307-314.
4. The ATBC Cancer Prevention Study Group. The alpha-tocopherol, beta-carotene lung cancer prevention study: design, methods, participant characteristics, and compliance. Ann Epidemiol 1994; 4:1-10.
5. Brock KE, Graubard BI, Fraser DR, Weinstein SJ, Stolzenberg-Solomon RZ, Lim U, Tangrea JA, Virtamo J, Ke L, Snyder K, Albanes D. Predictors of vitamin D biochemical status in a large sample of middle-aged male smokers in Finland. Eur J Clin Nutr 2010; 64:280-288.
6. Gillman MW, Kannel WB, Belanger A, D'Agostino RB. Influence of heart rate on mortality among persons with hypertension: the Framingham Study. Am Heart J 1993; 125:1148-1154.
7. Breslow NE, Day NE. Statistical methods in cancer research. Volume I -the analysis of case-control studies. IARC Sci Publ 1980;5-338.
8. Griffin FC, Gadegbeku CA, Sowers MR. Vitamin D and subsequent systolic hypertension among women. Am J Hypertens 2011; 24:316-321.
9. Jorde R, Figenschau Y, Emaus N, Hutchinson M, Grimnes G. Serum 25-hydroxyvitamin D levels are strongly related to systolic blood pressure but do not predict future hypertension. Hypertension 2010; 55:792-798.
10. Margolis KL, Martin LW, Ray RM, Kerby TJ, Allison MA, Curb JD, Kotchen TA, Liu S, Wassertheil-Smoller S, Manson JE. A prospective study of serum 25-hydroxyvitamin D levels, blood pressure, and incident hypertension in postmenopausal women. Am J Epidemiol 2012; 175: 22-32.
11. Wang L, Ma J, Manson JE, Buring JE, Gaziano JM, Sesso HD. A prospective study of plasma vitamin D metabolites, vitamin D receptor gene polymorphisms, and risk of hypertension in men. Eur J Nutr 2012 (doi: IO.1007/s00394-012-04880- 8) Last accessed 21 Dec 2012.
12. Forman JP, Curhan GC, Taylor EN. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension among young women. Hypertension 2008; 52:828-832.
13. Forman JP, Giovannucci E, Holmes MD, Bischoff-Ferrari HA, Tworoger SS, Willett WC, Curhan GC. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 2007; 49:1063-1069.
14. Elamin MB, Abu Elnour NO, Elamin KB, Fatourechi MM, Alkatib AA, Almandoz JP, Liu H, Lane MA, Mullan RJ, Hazem A, Erwin PJ, Hensrud DD, Murad MH, Montori VM. Vitamin D and cardiovascular outcomes: a systematic review and meta-analysis. J Clin Endocrinol Metab 2011; 96:1931-1942.
15. Scragg RK, Camargo CA Jr., Simpson RU. Relation of serum 25-hydroxyvitamin D to heart rate and cardiac work (from the National Health and Nutrition Examination Surveys). Am J Cardiol 2010; 105:122-128.
16. Pfeifer M, Begerow B, Minne HW, Nachtigall D, Hansen C. Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. J Clin Endocrinol Metab 2001; 86:1633-1637.
17. Scragg R, Khaw KT, Murphy S. Effect of winter oral vitamin D3 supplementation on cardiovascular risk factors in elderly adults. Eur J Clin Nutr 1995; 49:640-646.
18. Carrara D, Bernini M, Bacca A, Rugani I, Duranti E, Virdis A, Ghiadoni L, Taddei S, Bernini G. Cholecalciferol administration blunts the systemic renin-angiotensin system in essential hypertensives with hypovitaminosis D. J Renin Angiotensin Aldosterone Syst 2013 (doi:10.1177/1470320312471149) Last accessed 2 Jan 2013.
19. Mitri J, Muraru MD, Pittas AG. Vitamin D and type 2 diabetes: a systematic review. Eur J Clin Nutr 2011; 65:1005-1015.
20. Brondum-Jacobsen P, Benn M, Jensen GB, Nordestgaard BG. 25-hydroxyvitamin d levels and risk of ischemic heart disease, myocardial infarction, and early death: population-based study and metaanalyses of 18 and 17 studies. Arterioscler Thromb Vasc Biol 2012; 32: 2794-2802.